Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine for Disorders of Consciousness
NCT03623828Phase 2Unknown
- Sponsor
- University of Liège
- Start
- Oct 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of apomorphine in disorders of consciousness (DoC), sponsored by University of Liège. Primary endpoint: Coma Recovery Scale - Revised up to 90 days. Status: unknown.
02
Drugs
apomorphine
03
Conditions
disorders of consciousness (DoC)
Beyond the preview
Go deeper on NCT03623828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03623828.